[
1. Gardner DG, Shoback MD. Metabolic bone disease. In: Greenspan’s Basic & Clinical Endocrinology, Tenth Edition. Ohio: McGraw-Hill; 2018. p. 239-297.
]Search in Google Scholar
[
2. Castagna MG, Fugazzola L, Maino F, Covelli D, Memmo S, Sestini F, et al. Reference range of serum calcitonin in pediatric population. J Clin Endocrinol Metab. 2015 May;100(5):1780-4. DOI: 10.1210/jc.2014-450810.1210/jc.2014-450825955324
]Search in Google Scholar
[
3. Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American thyroid association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015 Jun;25(6):567-610. DOI: 10.1089/thy.2014.033510.1089/thy.2014.0335449062725810047
]Search in Google Scholar
[
4. Eckelt F, Vogel M, Geserick M, Kirsten T, Bae YJ, Baber R, et al. Calcitonin measurement in pediatrics: Reference ranges are gender-dependent, validation in medullary thyroid cancer and effects of thyroid diseases. Clin Chem Lab Med. 2019 Jun;57(8):1242-50. DOI: 10.1515/cclm-2018-118610.1515/cclm-2018-118630794525
]Search in Google Scholar
[
5. Danila R, Livadariu R, Branisteanu D. Calcitonin revisited in 2020. Acta Endocrinol (Buchar) 2019 Oct-Dec;15(4):544-8. DOI: 10.4183/aeb.2019.54410.4183/aeb.2019.544720011532377257
]Search in Google Scholar
[
6. Băetu M, Dobrescu R. Novel markers for early diagnosis and prognostic classification in medullary thyroid carcinoma. Acta Endocrinol (Buchar). 2017 Oct;13(4):519-522. DOI: 10.4183/aeb.2017.51910.4183/aeb.2017.519651654931149228
]Search in Google Scholar
[
7. Hillyard CJ, Oscier DG, Foa R, Catovsky D, Goldman JM. Immunoreactive calcitonin in leukaemia. Br Med J. 1979 Dec;2(6202):1392-3. DOI: 10.1136/bmj.2.6202.139210.1136/bmj.2.6202.13921597057519475
]Search in Google Scholar
[
8. Schwartz KE, Wolfsen AR, Forster B, Odell WD. Calcitonin in nonthyroidal cancer. J Clin Endocrinol Metab. 1979 Sep;49(3):438-44. DOI: 10.1210/jcem-49-3-43810.1210/jcem-49-3-438468977
]Search in Google Scholar
[
9. Toledo SPA, Lourenço DM, Santos MA, Tavares MR, Toledo RA, Correia-DeurI JE de M. Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics. 2009 Jul;64(7):699-706. DOI: 10.1590/S1807-5932200900070001510.1590/S1807-59322009000700015271044519606248
]Search in Google Scholar
[
10. Barbet J, Campion L, Kraeber-Bodéré F, et al. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 2005 Nov;90(11):6077-6084. DOI: 10.1210/jc.2005-004410.1210/jc.2005-004416091497
]Search in Google Scholar
[
11. Ito Y, Miyauchi A, Kihara M, et al. Calcitonin doubling time in medullary thyroid carcinoma after the detection of distant metastases keenly predicts patients’ carcinoma death. Endocr J 2016 Jul;63(7):663-7. DOI: 10.1507/endocrj.EJ16-014010.1507/endocrj.EJ16-014027097545
]Search in Google Scholar
[
12. LIAISON® XL | DiaSorin. Available from: https://www.diasorin.com/en/immunodiagnostic-solutions/systems/clia-systems/liaisonr-xl. Accessed Mar 19, 2021.
]Search in Google Scholar
[
13. Elecsys® Calcitonin. Available from: https://diagnostics.roche.com/global/en/products/params/elecsys-calcitonin.html. Accessed Mar 19, 2021.
]Search in Google Scholar
[
14. Kahaly GJ, Algeciras-Schimnich A, Davis TE, Diana T, Feldkamp J, Karger S, et al. United States and european multicenter prospective study for the analytical performance and clinical validation of a novel sensitive fully automated immunoassay for calcitonin. Clin Chem. 2017 Sep;63(9):1489-96. DOI: 10.1373/clinchem.2016.27000910.1373/clinchem.2016.27000928687633
]Search in Google Scholar
[
15. Kratzsch J, Petzold A, Raue F, Reinhardt W, Bröcker-Preuß M, Görges R, et al. Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Clin Chem. 2011 Mar;57(3):467-74. DOI: 10.1373/clinchem.2010.15168810.1373/clinchem.2010.15168821159900
]Search in Google Scholar
[
16. Shi J, Shi Q, Yuan S, Zhang W. Relationships between serum procalcitonin level, severity and different stresses of non-septic critically ill patients. Rev Romana Med Lab. 2020;28(1):49-56. DOI:10.2478/rrlm-2020-000310.2478/rrlm-2020-0003
]Search in Google Scholar
[
17. Vashist SK, Luong JHT. Handbook of Immunoassay Technologies: Approaches, Performances, and Applications. London: Academic Press; 2018. DOI: 10.1016/B978-0-12-811762-0.05001-510.1016/B978-0-12-811762-0.05001-5
]Search in Google Scholar
[
18. Ross DS. Medullary thyroid cancer: Surgical treatment and prognosis - UpToDate Available from: https://www.uptodate.com/contents/diagnostic-approach-to-and-treatment-of-thyroid-nodules. Accessed Mar 19, 2021.
]Search in Google Scholar
